We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Safety, Effectiveness of Pfizer’s Vaccine Candidate Will Be Known in October, CEO Says
Safety, Effectiveness of Pfizer’s Vaccine Candidate Will Be Known in October, CEO Says
Pfizer’s CEO Albert Bourla said that it is “highly likely” that the ongoing phase 3 trial of its mRNA-based COVID-19 vaccine candidate, BNT162, will show in October whether the vaccine is safe and effective — and said the company plans to seek the FDA’s approval the same month if the data support it.